The University of Chicago Header Logo

Connection

Olatoyosi Odenike to Epigenesis, Genetic

This is a "connection" page, showing publications Olatoyosi Odenike has written about Epigenesis, Genetic.
Connection Strength

0.255
  1. A phase I and pharmacodynamic study of the histone deacetylase inhibitor belinostat plus azacitidine in advanced myeloid neoplasia. Invest New Drugs. 2015 Apr; 33(2):371-9.
    View in: PubMed
    Score: 0.095
  2. The dawn of the molecular era of the myelodysplastic syndromes. N Engl J Med. 2011 Jun 30; 364(26):2545-6.
    View in: PubMed
    Score: 0.075
  3. Leukaemogenesis: more than mutant genes. Nat Rev Cancer. 2010 Jan; 10(1):23-36.
    View in: PubMed
    Score: 0.067
  4. An integrated genomic approach to the assessment and treatment of acute myeloid leukemia. Semin Oncol. 2011 Apr; 38(2):215-24.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.